415 related articles for article (PubMed ID: 24002671)
1. Cellular and molecular mechanisms of endothelial dysfunction in diabetes.
Roberts AC; Porter KE
Diab Vasc Dis Res; 2013 Nov; 10(6):472-82. PubMed ID: 24002671
[TBL] [Abstract][Full Text] [Related]
2. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
3. Vascular complications in diabetes mellitus: the role of endothelial dysfunction.
Schalkwijk CG; Stehouwer CD
Clin Sci (Lond); 2005 Aug; 109(2):143-59. PubMed ID: 16033329
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of hypertension in diabetes.
Stas SN; El-Atat FA; Sowers JR
Rev Endocr Metab Disord; 2004 Aug; 5(3):221-5. PubMed ID: 15211093
[No Abstract] [Full Text] [Related]
5. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
Rask-Madsen C; King GL
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction in metabolic and vascular disorders.
Polovina MM; Potpara TS
Postgrad Med; 2014 Mar; 126(2):38-53. PubMed ID: 24685967
[TBL] [Abstract][Full Text] [Related]
8. Why does diabetes mellitus increase the risk of cardiovascular disease?
Shahab A
Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
[TBL] [Abstract][Full Text] [Related]
9. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
Mafrici A; Proietti R
G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
[TBL] [Abstract][Full Text] [Related]
10. Potential manipulation of endothelial progenitor cells in diabetes and its complications.
Fadini GP; Avogaro A
Diabetes Obes Metab; 2010 Jul; 12(7):570-83. PubMed ID: 20590732
[TBL] [Abstract][Full Text] [Related]
11. The endothelial dysfunction in diabetes mellitus.
Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P; Ghanim H; Chaudhuri A; Mohanty P
J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
[TBL] [Abstract][Full Text] [Related]
14. The endothelium and vascular inflammation in diabetes.
Hartge MM; Unger T; Kintscher U
Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium.
Ding H; Triggle CR
Vasc Health Risk Manag; 2005; 1(1):55-71. PubMed ID: 17319098
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets.
Madonna R; De Caterina R
Vascul Pharmacol; 2011; 54(3-6):75-9. PubMed ID: 21453785
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis.
Zeadin MG; Petlura CI; Werstuck GH
Can J Diabetes; 2013 Oct; 37(5):345-50. PubMed ID: 24500563
[TBL] [Abstract][Full Text] [Related]
18. Targeting the endothelium to prevent diabetes-related atherosclerosis.
Kearney MT
Diab Vasc Dis Res; 2010 Jul; 7(3):177. PubMed ID: 20699387
[No Abstract] [Full Text] [Related]
19. Lipid inflammatory mediators in diabetic vascular disease.
Natarajan R; Nadler JL
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1542-8. PubMed ID: 15166011
[TBL] [Abstract][Full Text] [Related]
20. Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
Prattichizzo F; Giuliani A; De Nigris V; Pujadas G; Ceka A; La Sala L; Genovese S; Testa R; Procopio AD; Olivieri F; Ceriello A
Diabetes Obes Metab; 2016 Sep; 18(9):855-67. PubMed ID: 27161301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
